Completed NA INTERVENTIONAL 2-arm NCT06047145

Evaluation of Soy Isoflavones on Skin Ageing Parameters (ISOSKIN)

Evaluation of Oral Soy Isoflavone Concentrates on Skin Ageing Parameters: a Double-blind Randomised Placebo-controlled Trial

Sponsor: Eurofins Dermscan Pharmascan

Conditions Skin Ageing

Interventions Placebo soy isoflavones

Updated 7 times since 2023 Last updated: Apr 8, 2025 Started: Oct 27, 2023 Primary completion: Feb 26, 2024 Completion: Feb 26, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Skin Ageing and is currently completed. Eurofins Dermscan Pharmascan leads this study, which shows 7 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

May 2025 — Present [monthly]

Completed NA
Sep 2024 — May 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Apr 2024 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Feb 2024 — Apr 2024 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Dec 2023 — Feb 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Oct 2023 — Dec 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eurofins Dermscan Pharmascan
The Archer-Daniels-Midland Company

Data source: The Archer-Daniels-Midland Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Villeurbanne, France